alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 10.23

BONUS ARRANGEMENTS OF NAMED EXECUTIVE OFFICERS

On July 17, 2007, the Compensation Committee of the Board of Directors (the "Compensation Committee") of Synta Pharmaceuticals Corp. (the "Company")
approved a cash bonus plan applicable to all of the Company's employees. Pursuant to this plan, the Company's Named Executive Officers may be eligible to receive the following bonuses for service
during a fiscal year:

Named Executive Officer

Bonus Target
(As a % of Base Salary)Safi R. Bahcall, Ph.D.
President and Chief Executive Officer

50
%Keith S. Ehrlich, C.P.A.
Vice President, Finance and Administration,
Chief Financial Officer

30
%Martin D. Williams
Senior Vice President, Commercial and Business
Development, Chief Business Officer

40
%Eric W. Jacobson, M.D.
Senior Vice President, Clinical Research and
Regulatory Affairs, Chief Medical Officer

40
%Keizo Koya, Ph.D.
Senior Vice President, Drug Development

40
%


Pursuant
to the plan, the overall size of the cash bonus pool is to be set by the Company's Board of Directors each year, based on their assessment of the Company's performance relating to corporate
goals established by the Board. In January 2007, the Board established goals for the year ending December 31, 2007 relating to advancement of the Company's pipeline of drug candidates,
completion of a partnership and completion of the Company's initial public offering (which was completed in February 2007).

Payment
of a cash bonus under the plan is conditioned on the executive remaining employed by the Company at the time the award is actually made. Historically, the Company has made its annual
performance awards and adjustments in March. In addition, the Compensation Committee retains the discretion to award more or less than the target percentages in the approved plan on a
case-by-case basis.

---



QuickLinks
Exhibit 31.1  Section 302 Certification of Chief Executive Officer and Chief Financial Officer   I,  Justin Craig, certify that:  1. I have reviewed this quarterly report on Form 10-QSB of Medical Design Studios, Inc.  2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;  3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;  4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and have:  a) designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this quarterly report is being prepared;  b) evaluated the effectiveness of the registrants disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the Evaluation Date); and  c) presented in this quarterly report my conclusions about the effectiveness of the disclosure controls and procedures based on my evaluation as of the Evaluation Date;  5. I have disclosed, based on my most recent evaluation, to the registrants auditors and the audit committee of registrants board of directors (or persons performing the equivalent functions):  a) all significant deficiencies in the design or operation of internal controls which could adversely affect the registrants ability to record, process, summarize and report financial data and have identified for the registrants auditors any material weaknesses in internal controls; and  b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal controls  6. I have indicated in this quarterly report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of my most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.  Date: August 14, 2007  /s/  Justin Craig Justin Craig Title: President and Chief Financial Officer
EXHIBIT 31.1

Sarbanes-Oxley Act Section 302 Certification of Michael F. Crowley, Jr.



CERTIFICATION



I,
Michael F. Crowley, Jr., certify that:



1. I
have reviewed this annual report on Form 10-K of SeraCare Life Sciences, Inc.;



2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;



3. Based on my knowledge, the financial statements, and other financial information included in this report,
fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;



4. The registrants other certifying officer and I are responsible for establishing and maintaining
disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and we have:



a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our
supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;



b) evaluated the effectiveness of the
registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and



c) disclosed in this report any change in the
registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is
reasonably likely to materially affect, the registrants internal control over financial reporting; and



5. The registrants other certifying officer and I have disclosed, based on our most recent evaluation of internal control over
financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions):



a) all significant deficiencies and material weaknesses in the design or operation of internal control over
financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and



b) any fraud, whether or not material, that involves management or other employees who have a significant
role in the registrants internal control over financial reporting.



Date: December 14, 2004



|                                                
|------------------------------------------------
|/s/    MICHAEL F. CROWLEY,
JR.                  
|Michael F. Crowley, Jr., Chief Executive Officer
**Exhibit12.1****Certification of the principal executive officer of****Quebecor Media Inc.****pursuant to Section 302 of the Sarbanes-Oxley Act of 2002**I, Pierre Karl Péladeau, Vice Chairman and Chief Executive Officer of Quebecor Media Inc. (the“Company”), certify that:1. I have reviewed this annual report on Form 20-F of the Company; 2. Based on my knowledge, this report does not contain any untrue statement of a materialfact or omit to state a material fact necessary to make the statements made, in light ofthe circumstances under which such statements were made, not misleading with respect tothe period covered by this report; 3. Based on my knowledge, the financial statements, and other financial information includedin this report, fairly present in all material respects the financial condition, resultsof operations and cash flows of the Company as of, and for, the periods presented in thisreport; 4. The Company’s other certifying officer(s) and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)and 15d-15(e)) for the Company and have: a) Designed such disclosure controls and procedures, or caused suchdisclosure controls and procedures to be designed under our supervision, toensure that material information relating to the Company, including itsconsolidated subsidiaries, is made known to us by others within those entities,particularly during the period in which this report is being prepared;  b) [omitted pursuant to the guidance of Commission ReleasesNos.33-8238 (June 5, 2003) and 33-8618 (September 22, 2005)];  c) Evaluated the effectiveness of the Company’s disclosure controlsand procedures and presented in this report our conclusions about theeffectiveness of the disclosure controls and procedures, as of the end of theperiod covered by this report based on such evaluation; and  d) Disclosed in this report any change in the Company’s internalcontrol over financial reporting that occurred during the period covered by theannual report that has materially affected, or is reasonably likely tomaterially affect, the Company’s internal control over financial reporting; and5. The Company’s other certifying officer(s) and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the company’s auditors and theaudit committee of the Company’s board of directors (or persons performing the equivalentfunctions): a) All significant deficiencies and material weaknesses in the designor operation of internal control over financial reporting which are reasonablylikely to adversely affect the Company’s ability to record, process, summarizeand report financial information; and  b) Any fraud, whether or not material, that involves management orother employees who have a significant role in the Company’s internal controlover financial reporting.        Date:  February 8, 2008 /s/ Pierre Karl Péladeau   Name:  Pierre Karl Péladeau   Title:  Vice Chairman and Chief Executive Officer
EXHIBIT 32.1

                            CERTIFICATION PURSUANT TO
                 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Ronald L. Marquardt, hereby certify, pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

     (1)  the Quarterly Report on Form 10-Q of Winchester International Resorts
          Inc. for the period ended December 31, 2009 (the "Report") fully
          complies with the requirements of Section 13(a) or 15(d) of the
          Securities Exchange Act of 1934; and

     (2)  the information contained in the Report fairly presents, in all
          material respects, the financial condition and results of operations
          of Winchester International Resorts Inc.

Dated: February 19, 2010

                                 /s/ Ronald L. Marquardt
                                 -----------------------------------------------
                                 Ronald L. Marquardt
                                 President, Chief Operating Officer and Director
                                 (Principal Executive Officer)
                                 Winchester International Resorts Inc.

A signed original of this written statement required by Section 906, or other
document authenticating, acknowledging, or otherwise adopting the signature that
appears in typed form within the electronic version of this written statement
required by Section 906, has been provided to Winchester International Resorts
Inc. and will be retained by Winchester International Resorts Inc. and furnished
to the Securities and Exchange Commission or its staff upon request.
[Federal Register Volume 66, Number 93 (Monday, May 14, 2001)]
[Notices]
[Page 24359]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-11973]


-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. CP99-580-002]


Southern LNG Inc.; Notice of Site Visit

May 8, 2001.
    On May 17, 2001, at 9 a.m., staff from the Office of Energy 
Projects (OEP) will conduct a pre-certification site visit of the 
proposed Sendout Modification Project at Southern LNG Inc.'s (Southern 
LNG) existing liquefied natural gas import terminal on Elba Island near 
Savannah, Georgia. Representatives of Southern LNG will accompany the 
OEP staff.
    At 1:30 p.m. on May 17, 2001, OEP staff and Southern LNG will 
conduct an informal Plant Open House to discuss general LNG issues.
    All interested parties may attend the site visit and/or open house. 
Those planning to attend must provide their own transportation. For 
further information on attending the site visit or open house, please 
contact the Commission's Office of External Affairs at (202) 208-0004.

Linwood A. Watson, Jr.,
Acting Secretary.
[FR Doc. 01-11973 Filed 5-11-01; 8:45 am]
BILLING CODE 6717-01-M
I 

116TH CONGRESS 

1ST SESSION H. R. 2177 

To amend the Internal Revenue Code of 1986 to make members of health 

care sharing ministries eligible to establish health savings accounts. 

IN THE HOUSE OF REPRESENTATIVES 

APRIL 9, 2019 

Mr. KELLY of Pennsylvania (for himself, Mr. PETERSON, Mr. BIGGS, Mr. 

MOONEY of West Virginia, Mr. SMUCKER, Mr. HUDSON, Mr. WALKER, 

Mr. PALMER, Mr. KING of Iowa, Mr. MEADOWS, Mr. BABIN, Mr. SMITH

of New Jersey, Mr. RODNEY DAVIS of Illinois, Mr. ALLEN, Mrs. 

HARTZLER, Mr. LAMBORN, Mrs. WALORSKI, Mr. KINZINGER, Mr. 

MASSIE, Mr. HIGGINS of Louisiana, Mrs. RODGERS of Washington, and 

Mr. SMITH of Nebraska) introduced the following bill; which was referred 

to the Committee on Ways and Means 

A BILL 

To amend the Internal Revenue Code of 1986 to make 

members of health care sharing ministries eligible to 

establish health savings accounts. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Faith in Health Sav5 ings Accounts Act of 2019’’. 


kjohnson on DSK79L0C42 with BILLS
2 

•HR 2177 IH

1 SEC. 2. MEMBERS OF HEALTH CARE SHARING MINISTRIES 

2 ELIGIBLE TO ESTABLISH HEALTH SAVINGS 

3 ACCOUNTS. 

4 (a) IN GENERAL.—Section 223 of the Internal Rev5 enue Code of 1986 is amended by adding at the end the 

6 following new subsection: 

7 ‘‘(i) APPLICATION TO HEALTH CARE SHARING MIN8 ISTRIES.—For purposes of this section, membership in a 

9 health care sharing ministry (as defined in section 

10 5000A(d)(2)(B)(ii)) shall be treated as coverage under a 

11 high deductible health plan.’’. 

12 (b) EFFECTIVE DATE.—The amendment made by 

13 this section shall apply to taxable years beginning after 

14 the date of the enactment of this Act. 

Æ 


kjohnson on DSK79L0C42 with BILLS
#### Shoff v. Wells.

1. New trial : *Assault and battery.*In an action for assault and battery, a new trial will not be granted on account of the smallness of damages awarded by the verdict.

2. -: *Error.*If it be granted and another trial take place, at which larger damages are awarded by the jury, all proceedings after the first verdict will be set aside, and judgment be ordered on that verdict.

This was a petition in error to bring up a judgment rendered by the District Court for Otoe county, for review. It was an action for damage for an assault and battery, committed by the defendant upon the plaintiff. The cause was tried at the December term, 1868, before the court and a jury. The testimony showed that the plaintiff paid a physician fifteen dollars for medical attendance, rendered necessary by the injuries inflicted upon him,, and tended to show that for ten days he was unable to work, and that four dollars per day was what he could have earned. The jury rendered a verdict for seventeen dollars and fifty cents.' The plaintiff moved for a new trial on the ground that the damages awarded were inadequate. The court granted the motion. The pleadings were amended and reformed by the parties, and another trial was had at the March term, 1869, before the court and jury, which resulted in a verdict for the plaintiff for thirty-seven dollars and ten cents. The defendant moved to arrest the judgment, which the court refused to do, and entered judgment for the amount of the verdict and costs.

*I. IT. Shcimbaugh,*for plaintiff in error.

*G. W.*Seymour, for defendant in error.

Ceounse, J.

*169In article six of *the*Code relating to new trials it is provided :

“ Sec. 315. A new trial shall not be granted, on account of the smallness of damages, in an action for an injury to the person or reputation, nor any other action where the damages shall equal the actual pecuniary injury sustained.”

The reading and intérpretation contended for by the counsel for the defendant in error, is that in an action for damages for an injury to the person or reputation, as well as in all other actions, the damages must equal the actual pecuniary injury sustained.

This claim is opposed not only to the letter but to the obvious spirit of the section.

In cases of assault and battery, libel and slander, so many matters in aggravation or justification are disclosed upon the trial, that it is left for the jury to determine, in view of all the circumstances, what should be given as damages. With their findings, courts rarely interfere. Scarcely a case can be found where a new trial has been granted, because of the smallness of the damages assessed. This section, we think, is but declaratory of the practice which has so long obtained.

The case must be remanded with directions to reinstate the first verdict, and to set aside all proceedings subsequent thereto.

Cause remanded with directions.
Exhibit 12.2



I, Richard Whatley, Chief Financial Officer, certify that:



1.

I have reviewed this Annual Report on Form 20-F of

Alpha Gold Corporation;



2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Annual Report;



3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;



4.

The Companys other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the company and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in that this report is being prepared;

(b)

Evaluated the effectiveness of the companys disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(c)

Evaluated the effectiveness of the company's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)

Disclosed in this report any change in the companys internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the companys internal control over financial reporting; and



5.

The Companys other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the companys auditors and the audit committee of the companys board of directors (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the companys ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the companys internal control over financial reporting.





Date:

July 30, 2008



/s/

Richard Whatley

Richard Whatley, Chief Financial Officer/Secretary/Director





#